Latest Mylan Stories
Mylan Remains Committed to the Compelling, Legally-Binding Commitment to Acquire Perrigo to Generate Significant Value for Shareholders and All Other Stakeholders POTTERS BAR, England and PITTSBURGH,
POTTERS BAR, England and PITTSBURGH, May 5, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S.
- Expects to be eligible for 180 days of marketing exclusivity - POTTERS BAR, England and PITTSBURGH, May 5, 2015 /PRNewswire/ -- Mylan N.V.
ATLANTA and CAMBRIDGE, Mass., May 4, 2015 /PRNewswire/ -- Inhibikase Therapeutics, Inc. announces the election of Richard Fante, former President of AstraZeneca U.S.A.
POTTERS BAR, England and HYDERABAD, India, May 4, 2015 /PRNewswire/ -- Mylan N.V.
Mylan to Provide Update on Proposed Perrigo Transaction POTTERS BAR, England, April 27, 2015 /PRNewswire/ -- Mylan N.V.
Offer Significantly Below Prior Proposal Based on Unaffected Mylan Stock Price DUBLIN, April 24, 2015 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO,
THE DISTRIBUTION OF THIS COMMUNICATION IN CERTAIN JURISDICTIONS MAY BE RESTRICTED OR AFFECTED BY THE LAWS OF SUCH JURISDICTIONS.
LONDON, April 23, 2015 /PRNewswire/ -- This report analyses the global market for active pharmaceutical ingredients for the period from 2012 to 2020.
POTTERS BAR, England and HYDERABAD, India, April 23, 2015 /PRNewswire/ -- Mylan N.V.
- The abrogation of a law by a higher authority; annulment.